Alan Friedman

Alan Friedman is Professor of Pediatric Oncology at Johns Hopkins University. He attended Harvard Medical School and did his pediatric residency at Boston Children’s Hospital, before coming to Baltimore in 1986 for Fellowship training. His laboratory focuses on regulation of myeloid cell development and leukemic transformation by transcription factors and has pioneered the use of immature myeloid cells lacking NF-κB p50 (p50-IMC) as immunotherapy for cancer.